Pharmacokinetics of diphenhydramine in healthy volunteers with a dimenhydrinate 25 mg chewing gum formulation

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 25, Issue 5, 2003, Pages 377-381

  Valoti, Massimo ^a   Frosini, M ^a   Dragoni, S ^a   Fusi, F ^a   Sgaragli, G ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Chewing gum formulation; Dimenhydrinate; Diphenhydramine; Pharmacokinetics

Indexed keywords

DIMENHYDRINATE; DIPHENHYDRAMINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHEWING GUM; CONTROLLED STUDY; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; FEMALE; GAS LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PERMISSIBLE DOSE; MOTION SICKNESS; NORMAL HUMAN; PHARMACOKINETICS; PLASMA CLEARANCE;

EID: 0037480819     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2003.25.5.769660     Document Type: Article

References (22)

1. Babe, K.S., Seralin, W.E. Histamine, Bradykinin and their antagonists. In: The Pharmacological Basis of Therapeutics, 9th ed. Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., Gilman, A.G. (Eds.). McGraw-Hill: New York 1996, 581-600.
2. Cohen, B., DeJong, J.M. Meclizine and placebo in treating vertigo of vestibular origin. Relative efficacy in a double-blind study. Arch Neurol 1972, 27: 129-35.
3. Martindale: The Complete Drug Reference. 32nd ed. Parfitt, K. (Ed.). Pharmaceutical Press: London 1999, 409.
4. Scavone, J.M., Luna, B.G., Harmatz, J.S., von Moltke, L., Greenblatt, D.J. Diphenhydramine kinetics following intravenous, oral, and sublingual dimenhydrinate administration. Biopharm Drug Dispos 1990, 11: 185-9.
5. Scavone, J.M., Greenblatt, D.J., Harmatz, J.S., Engelhardt, N., Shader, R.I. Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers. Clin Pharmacol 1998, 38: 603-9.
6. Schulz, M., Schmoldt, A. Therapeutic and toxic blood concentrations of more than 500 drugs. Pharmazie 1997, 52: 895-911.
7. Carruthers, S.G., Shoeman, D.W., Hignite, C.E., Azarnoff, D.L. Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Pharmacol Ther 1978, 23: 375-82.
8. Licko, V., Thompson, T., Barnett, G. Asynchronies of diphenhydramine plasmo-performance relationships. Pharmacol Biochem Behav 1986, 25: 365-70.
9. Gengo, F., Gabos, C., Miller, J.K. The pharmacodynamics of diphenhydramine-induced drowsiness and changes in mental perfomance. Clin Pharmacol Ther 1989, 45: 15-21.
10. Abernethy, D.R., Greenblatt, D.J. Diphenhydramine determination in human plasma by gas-liquid chromatography using nitrogen-phosphorus detection. Application to single low-dose pharmacokinetic studies. J Pharm Sci 1983, 72: 941-3.
11. Ninci, R., Giovannini, M.G., Della Corte, L., Sgaragli, G.P. Isothermal gas chromatographic determination of nanogram amounts of chlorimipramine, chlorpromazine and their N-desmethyl metabolites in plasma using nitrogen-selective detection. J Chromatogr 1986, 381: 315-22.
12. Dahl, S.G., Jacobsen, S. GLC determination of methotrimeprazine and its sulfoxide in plasma. J Pharm Sci 1976, 65: 1329-33.
13. Shumaker, R.C. PKALC: A BASIC interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab Rev 1986, 17: 331-48.
14. Holford, N. MK Model. An extended least squares underling program. Biosoft: Cambridge 1988.
15. Peck, C.C., Beal, S.L., Sheiner, L.B., Nichols, A.I. A possible solution to the choice of weights problem in analysis of individual pharmacokinetic data. J Pharmacokinet Biopharm 1984, 12: 545-58.
16. Albert, K.S., Hallmark, M., Akmar, R., Weidler, D.J., Wagner, J.G. Pharmacokinetics of diphenhydramine in man. Pharmacokinet Biopharm 1975, 3: 159-70.
17. Blyden, G.T., Greenblatt, D.J., Scavone, J.M., Shader, R.I. Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administration. J Clin Pharmacol 1986, 26: 529-33.
18. Seibel, K., Schaffler, K., Reitmeir, P. A randomized, placebo-controlled study comparing two formulations of dimenhydrinate with respect to efficacy in motion sickness and sedation. Arzneimittelforschung 2002, 52: 529-36.
19. Skofitsch, G., Lembeck, F. Serum levels of dimenhydrinate. Determination by HPLC wilh UV detection after intake of dimenhydrinate in a coated chewing gum dragee. Arzneimittelforschung 1983, 33: 1674-6.
20. Simons, K.J., Watson, W.T., Martin, T.J., Chen, X.Y., Simons, F.E. Diphenhydramine: Pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children. J Clin Pharmacol 1990, 30: 665-71.
21. Cristrupp, L.L., Bonde, J., Rasmussen, S.N., Rassing, M.R. Relative bioavailability of (±)-verapamil hydroclorid administered in tablets and chewing gum. Acta Pharm Nord 1990, 2: 371-6.
22. Bosquet, E., Tirendi, S., Bonina, F.P., Montenegro, L., Bianchi, A., Ciampini, N. Bioavailability of two formulations of acetylsalicylic acid acid gum. Pharmazie 1992, 47: 607-9.